Search Results - "Kononova, N. V"
-
1
A New Human Uveal Melanoma Cell Line: Melanin Production and Molecular Markers for Targeted Therapy
Published in Biochemistry (Moscow). Supplement. Series B, Biomedical chemistry (01-12-2023)“…A new human uveal melanoma (UM) cell line uMel1 was established by mechanical disintegration of a tumor fragment. uMel1 cells had a stellate dendrite-like…”
Get full text
Journal Article -
2
Development and optimization of several stages of the technological process of filgrastim substance production
Published in Applied biochemistry and microbiology (01-12-2010)“…Technology of industrial production of an active pharmaceutical substance (APS) of the recombinant human granulocyte colony-stimulating factor (rhG-CSF)…”
Get full text
Journal Article -
3
The use of ridge regression for estimating the severity of acute pancreatitis
Published in Bi͡u︡lletenʹ Sibirskoĭ medit͡s︡iny (27-10-2019)“…Purpose. Increasing of treatment efficiency for patients with acute pancreatitis by improving objective means of determining the severity of acute…”
Get full text
Journal Article -
4
Recombinant granulocyte colony-stimulating factor (filgrastim): Optimization of conjugation conditions with polyethylene glycol
Published in Russian journal of bioorganic chemistry (01-09-2012)“…With the purpose of creating an active prolonged-release pharmaceutical substance, modification of the recombinant human granulocyte colony-stimulating factor…”
Get full text
Journal Article -
5
Recombinant granulocyte-colony stimulating factor (filgrastim): optimization of conditions of isolation and purification from inclusion body
Published in Bioorganicheskaia khimiia (01-09-2014)“…We developed a unified process platform for two recombinant human GCSF medicines--one with the non-prolonged and the other with prolonged action. This unified…”
Get more information
Journal Article -
6
Recombinant granulocyte-colony stimulating factor (filgrastim): optimization of conjugation with polyethylene glycol
Published in Bioorganicheskaia khimiia (01-09-2012)“…In order to create an active pharmaceutical substance of the drug with prolonged action the modification of recombinant human granulocyte colony-stimulating…”
Get more information
Journal Article -
7
Solubilization Specificities Interferon beta-1b from Inclusion Bodies
Published in Bioorganicheskaia khimiia (01-07-2015)“…A new solubilization method of recombinant interferon beta-1b (IFNβ-1b) from the inclusion bodies was developed. This method allows to extract the target…”
Get more information
Journal Article -
8
Features of the solubilization of interferon beta-1B from inclusion bodies
Published in Russian journal of bioorganic chemistry (01-07-2015)“…A novel method for the solubilization of recombinant interferon beta-1b (IFNβ-1b) from inclusion bodies has been developed, which makes it possible to…”
Get full text
Journal Article -
9
Recombinant granulocyte colony stimulating factor (filgrastim) of prolonged action: Optimization of conditions for extraction and purification from inclusion bodies
Published in Russian journal of bioorganic chemistry (01-09-2014)“…A unified technology platform for the production of two medical products with nonprolonged and prolonged action on the basis of the recombinant human…”
Get full text
Journal Article -
10
Identification and structural analysis of a glycophospholipid component from the venom of ant Paraponera clavata
Published in Russian journal of bioorganic chemistry (01-09-2006)Get full text
Journal Article -
11
Identification and structural analysis of a glycophospholipid component from the venom of ant Paraponera clavata
Published in Bioorganicheskaia khimiia (01-09-2006)“…The venom of South American ant Paraponera clavata and its low-molecular-mass fraction were shown to possess insectotoxic and pore-forming activities. A number…”
Get more information
Journal Article -
12
Intracutaneous reactions in dysentery
Published in Žurnal mikrobiologii, ėpidemiologii i immunobiologii (01-07-1954)Get more information
Journal Article